Short Interest in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Declines By 88.1%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 36,079 shares, a decrease of 88.1% from the April 30th total of 303,052 shares. Based on an average trading volume of 676,732 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.9% of the shares of the stock are sold short.

Institutional Investors Weigh In On Defiance Daily Target 2X Long LLY ETF

An institutional investor recently bought a new position in Defiance Daily Target 2X Long LLY ETF stock. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,433 shares of the company’s stock, valued at approximately $138,000. Thurston Springer Miller Herd & Titak Inc. owned approximately 0.34% of Defiance Daily Target 2X Long LLY ETF as of its most recent SEC filing.

Defiance Daily Target 2X Long LLY ETF Price Performance

Shares of NYSEARCA:LLYX traded up $1.88 during midday trading on Thursday, reaching $25.01. 501,864 shares of the company were exchanged, compared to its average volume of 466,036. The business’s fifty day moving average is $18.18 and its two-hundred day moving average is $21.86. Defiance Daily Target 2X Long LLY ETF has a one year low of $9.60 and a one year high of $28.44.

Defiance Daily Target 2X Long LLY ETF Company Profile

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.